Correlation Between ENVVENO MEDICAL and HAPAG-LLOYD UNSPADR

Can any of the company-specific risk be diversified away by investing in both ENVVENO MEDICAL and HAPAG-LLOYD UNSPADR at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ENVVENO MEDICAL and HAPAG-LLOYD UNSPADR into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ENVVENO MEDICAL DL 00001 and HAPAG LLOYD UNSPADR 12, you can compare the effects of market volatilities on ENVVENO MEDICAL and HAPAG-LLOYD UNSPADR and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ENVVENO MEDICAL with a short position of HAPAG-LLOYD UNSPADR. Check out your portfolio center. Please also check ongoing floating volatility patterns of ENVVENO MEDICAL and HAPAG-LLOYD UNSPADR.

Diversification Opportunities for ENVVENO MEDICAL and HAPAG-LLOYD UNSPADR

-0.03

Correlation Coefficient

ENVVENO MEDICAL  HAPAG-LLOYD UNSPADR

Good diversification

The 3 months correlation between ENVVENO and HAPAG-LLOYD is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding ENVVENO MEDICAL DL 00001 and HAPAG LLOYD UNSPADR 12 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HAPAG LLOYD UNSPADR and ENVVENO MEDICAL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ENVVENO MEDICAL DL 00001 are associated (or correlated) with HAPAG-LLOYD UNSPADR. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HAPAG LLOYD UNSPADR has no effect on the direction of ENVVENO MEDICAL i.e., ENVVENO MEDICAL and HAPAG-LLOYD UNSPADR go up and down completely randomly.

Pair Corralation between ENVVENO MEDICAL and HAPAG-LLOYD UNSPADR

Assuming the 90 days horizon ENVVENO MEDICAL DL 00001 is expected to generate 1.25 times more return on investment than HAPAG-LLOYD UNSPADR. However, ENVVENO MEDICAL is 1.25 times more volatile than HAPAG LLOYD UNSPADR 12. It trades about -0.03 of its potential returns per unit of risk. HAPAG LLOYD UNSPADR 12 is currently generating about -0.08 per unit of risk. If you would invest  294.00  in ENVVENO MEDICAL DL 00001 on December 25, 2024 and sell it today you would lose (32.00) from holding ENVVENO MEDICAL DL 00001 or give up 10.88% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

ENVVENO MEDICAL DL 00001  vs.  HAPAG LLOYD UNSPADR 12

ENVVENO MEDICAL DL

Risk-Adjusted Performance

Very Weak

Over the last 90 days ENVVENO MEDICAL DL 00001 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

HAPAG LLOYD UNSPADR

Risk-Adjusted Performance

Very Weak

Over the last 90 days HAPAG LLOYD UNSPADR 12 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with ENVVENO MEDICAL and HAPAG-LLOYD UNSPADR

The main advantage of trading using opposite ENVVENO MEDICAL and HAPAG-LLOYD UNSPADR positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ENVVENO MEDICAL position performs unexpectedly, HAPAG-LLOYD UNSPADR can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HAPAG-LLOYD UNSPADR will offset losses from the drop in HAPAG-LLOYD UNSPADR's long position.

The idea behind ENVVENO MEDICAL DL 00001 and HAPAG LLOYD UNSPADR 12 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.